Biocon Biologics to acquire Viatris’ biosimilars business for $3.35B
Biocon Biologics Ltd (BBL), a Biocon subsidiary, announced the acquisition of Viatris' biosimilars business for $3.3 ...
Read moreBiocon Biologics Ltd (BBL), a Biocon subsidiary, announced the acquisition of Viatris' biosimilars business for $3.3 ...
Read moreTech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at info@techstory.in